KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Shares Outstanding (Diluted Average) (2019 - 2025)

Guardant Health (GH) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $125.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 2.14% to $125.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $125.4 million through Dec 2025, up 2.14% year-over-year, with the annual reading at $125.4 million for FY2025, 2.14% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $125.4 million in Q4 2025 for Guardant Health, up from $124.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $125.4 million in Q4 2025 to a low of $101.0 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $111.5 million across 5 years, with a median of $107.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.64% in 2022 and later rose 18.55% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $101.3 million in 2021, then increased by 0.85% to $102.2 million in 2022, then grew by 9.6% to $112.0 million in 2023, then increased by 9.61% to $122.7 million in 2024, then grew by 2.14% to $125.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for GH at $125.4 million in Q4 2025, $124.3 million in Q3 2025, and $124.1 million in Q2 2025.